Skip to main content

Table 2 Primary and secondary endpoints

From: Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial

Primary endpoint

• Changes in the IPSS 12 weeks after intervention

Secondary endpoints (see Figure 1 for time points)

 
 

• Changes in free uroflowmetry and post-void residual

 

• Changes in bladder diary

 

• Changes in urodynamic investigation

 

• Changes in IPSS, CPSI and IIEF

 

• Changes of haemoglobin and serum PSA

 

• Duration of post procedure catheterisation and hospitalisation

 

• Procedure time and radiation parameters

 

• Changes of prostate volume, measure of devascularized/resected tissue using MRI

 

• Comparison of prostate size, measured preoperatively by TRUS and MRI at baseline